Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica L Gören

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Psychosomatics|November 23, 2006
Hyperthyroidism associated with topiramate treatmentJessica L Gören
Expert Opinion on Drug Safety|May 9, 2008
Antidepressants use in pediatric populationsJessica L Gören
The Mental Health Clinician|June 30, 2018
Brain-derived neurotrophic factor and schizophreniaJessica L Gören
Rhode Island Medical Journal (2013)|May 4, 2013
Psychotropics and sudden cardiac deathJessica L Gören, Tuan Anh Dinh
Journal of Pharmacy Practice|September 24, 2011
The use of omega-3 fatty acids in mental illnessJessica L Gören, Ashley T Tewksbury
Pharmacotherapy|April 22, 2005
Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorderJennifer L Kirwin, Jessica L Gören
Psychiatric Services (Washington, D.C.)|February 28, 2017
The Business Case for Expanded Clozapine Utilization: In ReplyJessica L Gören, Adam J Rose, John P Ney
The Annals of Pharmacotherapy|March 13, 2014
Infection and inflammation leading to clozapine toxicity and intensive care: a case seriesJonathan G Leung, Sarah Nelson, Christopher R Takala, et al.
Psychiatric Services (Washington, D.C.)|June 16, 2016
The Business Case for Expanded Clozapine UtilizationJessica L Gören, Adam J Rose, Eric G Smith, et al.
International Journal of General Medicine|November 30, 2022
Treating Bipolar Disorder in Primary Care: Diagnosis, Pharmacology, and ManagementHeather Huang, Nicholas Nissen, Christopher T Lim, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Psychosomatics|November 23, 2006
Hyperthyroidism associated with topiramate treatmentJessica L Gören
Expert Opinion on Drug Safety|May 9, 2008
Antidepressants use in pediatric populationsJessica L Gören
The Mental Health Clinician|June 30, 2018
Brain-derived neurotrophic factor and schizophreniaJessica L Gören
Rhode Island Medical Journal (2013)|May 4, 2013
Psychotropics and sudden cardiac deathJessica L Gören, Tuan Anh Dinh
Journal of Pharmacy Practice|September 24, 2011
The use of omega-3 fatty acids in mental illnessJessica L Gören, Ashley T Tewksbury
Pharmacotherapy|April 22, 2005
Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorderJennifer L Kirwin, Jessica L Gören
Psychiatric Services (Washington, D.C.)|February 28, 2017
The Business Case for Expanded Clozapine Utilization: In ReplyJessica L Gören, Adam J Rose, John P Ney
The Annals of Pharmacotherapy|March 13, 2014
Infection and inflammation leading to clozapine toxicity and intensive care: a case seriesJonathan G Leung, Sarah Nelson, Christopher R Takala, et al.
Psychiatric Services (Washington, D.C.)|June 16, 2016
The Business Case for Expanded Clozapine UtilizationJessica L Gören, Adam J Rose, Eric G Smith, et al.
International Journal of General Medicine|November 30, 2022
Treating Bipolar Disorder in Primary Care: Diagnosis, Pharmacology, and ManagementHeather Huang, Nicholas Nissen, Christopher T Lim, et al.
Pageof 2